Growth Metrics

Myomo (MYO) Common Equity (2016 - 2025)

Myomo filings provide 10 years of Common Equity readings, the most recent being $14.6 million for Q3 2025.

  • On a quarterly basis, Common Equity rose 57.39% to $14.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $14.6 million, a 57.39% increase, with the full-year FY2024 number at $24.7 million, up 174.93% from a year prior.
  • Common Equity hit $14.6 million in Q3 2025 for Myomo, down from $17.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $24.7 million in Q4 2024 to a low of $6.4 million in Q4 2022.
  • Median Common Equity over the past 5 years was $11.0 million (2023), compared with a mean of $12.8 million.
  • Biggest five-year swings in Common Equity: crashed 58.73% in 2022 and later soared 174.93% in 2024.
  • Myomo's Common Equity stood at $15.4 million in 2021, then crashed by 58.73% to $6.4 million in 2022, then surged by 41.36% to $9.0 million in 2023, then surged by 174.93% to $24.7 million in 2024, then crashed by 40.82% to $14.6 million in 2025.
  • The last three reported values for Common Equity were $14.6 million (Q3 2025), $17.6 million (Q2 2025), and $21.7 million (Q1 2025) per Business Quant data.